Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
NuSirt Sciences Inc logo — company profile

NuSirt Sciences Inc

Founded 2007 United States Nashville, United States 2 employees Venture round Total: $15.98M Biotechnology

General Information

Company Name NuSirt Sciences Inc
Founded Year 2007
Location United States Nashville, United States
Founders / Decision Makers
Team member
Employees 2
Industries Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with NuSirt Sciences Inc. To contact NuSirt Sciences Inc, visit nusirt.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NuSirt Sciences Inc compare?

A PDF of NuSirt Sciences Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NuSirt Sciences Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NuSirt Sciences Inc

NuSirt Sciences Inc is a biopharmaceutical company headquartered in Nashville, TN with research labs in Knoxville, TN. Established in 2007, NuSirt focuses on developing innovative drugs for diabetes treatment and other metabolic disorders such as obesity, arteriosclerosis, and hyperlipidemia. Their leading product, NS-0100, utilizes a combination of the natural product leucine and a low dose of metformin for type II diabetes treatment. This approach aims to address the adverse gastrointestinal side effects that some patients experience with metformin, providing a potential alternative for those who cannot tolerate the traditional medication. Currently undergoing Phase 2 clinical trials to determine the most effective dosage, NuSirt's NS-0100 presents a promising alternative to metformin if successful. The company secured a $2.00M Venture Round investment on December 1, 2016. The investors involved in this round are not specified. NuSirt's innovative approach and potential market impact position it as an intriguing prospect in the biotechnology industry.

Business keywords: Biopharmaceutical, Metabolic disorders, Type II diabetes, Drug development, Clinical trials, Platform technology, Leucine, Metformin, Gastrointestinal side effects, Innovation, Patent applications, Research and development, Pharmaceutical agents, Healthcare innovation

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.00M -
01 Dec 2016
Series C $6.00M 4
Hatteras Venture Partners Tri-Star Health Partners
Hatteras Venture Partners, Tri-Star Health Partners +2
13 May 2015
Series B $1.80M 1
Mountain Group Capital
01 Jun 2014
Series A $3.50M 2
Tennessee Community Ventures, Mountain Group Capital
01 Mar 2014
Seed Round $2.08M 1
Tennessee Community Ventures
01 Sep 2012
Seed Round $600.00K 2
Tennessee Community Ventures, Mountain Group Capital
01 Jun 2012

NuSirt Sciences Inc Alternatives & Competitors

View All Alternatives
NuSirt Sciences Inc vs
DiObex
DiObex

Innovative biotechnology solutions for metabolic disorders.

Series B
Biotechnology, Health Care
NuSirt Sciences Inc vs
AdipoPharma SAS
AdipoPharma SAS France

French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and asso...

Venture round
7 employees
Biotechnology, Pharmaceutical
NuSirt Sciences Inc vs
OrsoBio
OrsoBio United States

Advancing first-in-class therapies to restore energy homeostasis

Series A
18 employees
Biopharma, Biotechnology
View all alternatives

FAQ About NuSirt Sciences Inc

NuSirt BioPharma is a privately held biopharmaceutical company headquartered in Nashville TN with research labs in Knoxville, TN. NuSirt is focused on the development of novel drugs for the treatment of diabetes and other metabolic disorders including obesity, arteriosclerosis, and hyperlipidemia. N...
NuSirt Sciences Inc was founded in 2007.
NuSirt Sciences Inc is headquartered in Nashville, United States.
NuSirt Sciences Inc operates in Biotechnology. Its work centres on Biopharmaceutical, Metabolic disorders, Type II diabetes and Drug development.
NuSirt Sciences Inc has approximately 2 employees.
NuSirt Sciences Inc has completed 6 funding rounds, raising a total of $15.98M. The latest funding stage is Venture round.
Top alternatives and competitors to NuSirt Sciences Inc include DiObex, AdipoPharma SAS, OrsoBio, Algiax Pharmaceuticals, AltrixBio Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NuSirt Sciences Inc and DiObex are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NuSirt Sciences Inc, https://bouncewatch.com/company/nusirt-sciences-inc, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes